SEN

Biofeedback For Adjunctive Treatment Of Symptoms Associated With Stress And Anxiety

Product code
SEN
Device name
Biofeedback For Adjunctive Treatment Of Symptoms Associated With Stress And Anxiety
Device class
Class 2
21 CFR
21 CFR 882.5050
Medical specialty
Neurology
Marketing pathway
510(K)
510(k) clearances (last 3 years)
1
Summaries archived here
0 (direct download)
510(k) clearances (all years, FDA)
1 (all years; only the last 3 years are listed here)

FDA classification definition

A biofeedback device for adjunctive treatment of patient-reported symptoms associated with stress and anxiety is intended to provide feedback to users with patient-reported symptoms associated with stress and anxiety on a physiological measurement as a relaxation treatment for the reduction of stress and anxiety.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (1)

Last three years. Most recent: 2025-04-24.

NumberDecision dateApplicantDevice nameSummary
K2333372025-04-24Freespira, Inc.Freespira Breathing System
Official FDA classification page: SEN
Classification and pathway per current FDA publications. Data from openFDA (CC0).